ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Sevilla, AN, ESP:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Seville, Spain and 59 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Sevilla, Spain and 78 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Active, not recruiting
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Seville, Spain and 54 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Seville, Spain and 228 other locations

parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D...

Enrolling
Type 1 Diabetes
Drug: Low Dose SAB-142
Other: Placebo

Phase 2

Sab Biotherapeutics

Seville, Spain and 60 other locations

the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes...

Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

Phase 3

Lilly
Lilly

Seville, Spain and 158 other locations

Locations recently updated

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obe...

Enrolling
Type 1 Diabetes
Overweight
Drug: Placebo
Drug: Tirzepatide

Phase 3

Lilly
Lilly

Seville, Spain and 78 other locations

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Seville, Sevilla, Spain and 99 other locations

Locations recently updated

The purpose of this study is to find out if baricitinib can preserve beta-cell function in participants newly diagnosed with type 1 diabetes...

Begins enrollment in 1 month
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

Phase 3

Lilly
Lilly

Seville, Spain and 127 other locations

Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

Phase 2

Roche
Roche

Seville, Spain and 51 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems